Lab
Laboratorio Clinico Central Naranjito, PSC.
Laboratorio Clinico Central Naranjito, PSC. was paid $314K by Medicaid between Jan 2018 and Dec 2024, across 35 billing codes. Its largest line is 84443, Thyroid stimulating hormone (TSH) — 19% of everything it billed.
33Billing provider infoLABORATORIO CLINICO CENTRAL NARANJITO, PSC.
NARANJITO, PR 00719
NARANJITO, PR 00719
33aNPI1134394794assigned 04/24/2008
33bProvider typeClinical Medical Laboratory
28Total paid$314K
24GClaims28,472
24DCodes billed35
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#367 of 777
Median peer was paid$278K
This provider vs. median1.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,245 | $76K | |
| 2019 | 1,130 | $12K | |
| 2020 | 2,305 | $24K | |
| 2021 | 3,974 | $44K | |
| 2022 | 4,351 | $52K | |
| 2023 | 4,492 | $49K | |
| 2024incomplete | 4,975 | $56K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 84443 | Thyroid stimulating hormone (TSH) | 19% | 3,484 | 3,321 | $58K |
| 80061 | Lipid panel | 15% | 3,465 | 3,291 | $46K |
| 80053 | Comprehensive metabolic panel | 13% | 4,006 | 3,753 | $42K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 13% | 5,257 | 4,876 | $41K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 6.3% | 825 | 766 | $20K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 5.8% | 615 | 576 | $18K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 4.9% | 621 | 590 | $15K |
| 83036 | Hemoglobin; glycosylated (A1C) | 4.6% | 1,458 | 1,371 | $14K |
| 81001 | 4.5% | 4,264 | 4,003 | $14K | |
| 82274 | 2.7% | 528 | 506 | $8K | |
| 84439 | 2.0% | 686 | 650 | $6K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.6% | 118 | 112 | $5K |
23 more codes
| 36415 | Collection of venous blood by venipuncture | 1.4% | 743 | $4K |
| 86328 | <1% | 128 | $2K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 53 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 154 | $2K |
| 82043 | <1% | 308 | $2K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 39 | $2K |
| 87088 | <1% | 186 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 157 | $1K |
| 84153 | <1% | 64 | $1K | |
| 82607 | <1% | 67 | $1K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 124 | $1K |
| 86738 | <1% | 69 | $1K | |
| 84436 | <1% | 104 | $730.35 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 578 | $608.37 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 14 | $535.36 |
| 86592 | <1% | 115 | $500.25 | |
| 82570 | <1% | 45 | $242.82 | |
| 82950 | <1% | 46 | $238.28 | |
| 85651 | <1% | 68 | $219.19 | |
| 85027 | <1% | 30 | $207.98 | |
| 84479 | <1% | 15 | $91.65 | |
| 82947 | <1% | 26 | $88.67 | |
| 85610 | <1% | 12 | $47.19 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFIGUEROA, NIXZALIZ (PRESIDENT)